Tubal, Bethany C.

HRN: 20-93-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2023
CEFUROXIME 750MG (VIAL)
07/21/2023
07/28/2023
IV
300mg
Q8hrs
AGE With Moderate DHN
Waiting Final Action 
07/21/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/21/2023
07/28/2023
IV
90
Q8hrs
AGE With Moderate DHN
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: